老年慢性支气管炎运用痰热清注射液联合头孢菌素治疗的疗效分析.docVIP

老年慢性支气管炎运用痰热清注射液联合头孢菌素治疗的疗效分析.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
老年慢性支气管炎运用痰热清注射液联合头孢菌素治疗的疗效分析   【摘要】 目的 探究在老年慢性支气管炎的临床治疗中结合痰清热注射液和头孢菌素治疗的临床应用效果。方法 168例老年慢性支气管炎患者, 随机分为对照组和观察组, 各84例。对照组患者应用头孢菌素进行治疗, 观察组患者在对照组药物应用的基础上结合痰清热注射液进行治疗。对比两组患者的临床治疗效果以及不良反应发生情况。结果 观察组治疗1、2、3周总有效率分别为54.8%、96.4%、98.8%, 均高于对照组的33.3%、66.7%、86.9%, 差异均具有统计学意义 (P0.05);观察组临床控制率为69.0%, 高于对照组的41.7%, 差异具有统计学意义 (P0.05)。观察组不良反应发生率为2.4%, 低于对照组的13.1%, 差异具有统计学意义 (P0.05) 。结论 在老年慢性支气管炎患者的临床治疗中应用痰热清注射液联合头孢菌素进行治疗能够显著改善患者的临床治疗效果, 同时后期的临床治疗不良反应发生率较低, 值得在临床治疗中推广应用。   【关键词】 老年慢性支气管炎;痰热清注射液;头孢菌素   DOI:10.14163/j.cnki.11-5547/r.2017.02.051   Analysis on curative effect of senile chronic bronchitis treated by Tanreqing injection combined with cephalosporin LIU Yun-zhi. Liaoning Province Lingyuan City Centers for Disease Control and Prevention, Lingyuan 122500, China   【Abstract】 Objective To explore the clinical application effect of senile chronic bronchitis treated by Tanreqing injection combined with cephalosporin. Methods A total of 168 senile chronic bronchitis patients were randomly divided into conctrol group and observation group, with 84 cases in each group. The control group received cephalosporin for treatment, and the observation group received Tanreqing injection for treatment on the basis of the control group. Comparison were made on clinical treatment effect and adverse reactions in two groups. Results The observation group had total effective rate in 1, 2 and 3 weeks respectively as 54.8%, 96.4% and 98.8%, which were higher than 33.3%, 66.7% and 86.9% in the control group, and their differences had statistical significance (P0.05). The observation group had higher clinical control rate as 69.0% than 41.7% in the control group, and the difference had no statistical significance (P0.05). The observation group had lower incidence of adverse reactions as 2.4% than 13.1% in the control group, and the difference had no statistical significance (P0.05). Conclusion Tanreqing injection combined with cephalosporin can significantly improve the clinical treatment effect

文档评论(0)

小马过河 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档